These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7931492)

  • 1. Neurotoxicity of purine analogs: a review.
    Cheson BD; Vena DA; Foss FM; Sorensen JM
    J Clin Oncol; 1994 Oct; 12(10):2216-28. PubMed ID: 7931492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes insipidus and Guillain-Barré-like syndrome following CAR-T cell therapy: a case report.
    Koch C; Fleischer J; Popov T; Frontzek K; Schreiner B; Roth P; Manz MG; Unseld S; Müller AMS; Russkamp NF
    J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36690387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxic leukoencephalopathy with axonal spheroids caused by chemotherapeutic drugs other than methotrexate.
    Lim KY; Kim SI; Kim H; Kang J; Park JW; Won JK; Shin DY; Park SH
    BMC Neurol; 2022 Aug; 22(1):288. PubMed ID: 35922754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of inflammation and oxidative stress in chemotherapy-induced neurotoxicity.
    Gupta P; Makkar TK; Goel L; Pahuja M
    Immunol Res; 2022 Dec; 70(6):725-741. PubMed ID: 35859244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Review of Acute and Long-Term Neurological Complications Following Haematopoietic Stem Cell Transplant for Paediatric Acute Lymphoblastic Leukaemia.
    Gabriel M; Hoeben BAW; Uhlving HH; Zajac-Spychala O; Lawitschka A; Bresters D; Ifversen M
    Front Pediatr; 2021; 9():774853. PubMed ID: 35004543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and treatment of hairy cell leukemia as the COVID-19 pandemic continues.
    Kreitman RJ; Arons E
    Blood Rev; 2022 Jan; 51():100888. PubMed ID: 34535326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of Recombinant Immunotoxins for Hairy Cell Leukemia.
    Kreitman RJ; Pastan I
    Biomolecules; 2020 Aug; 10(8):. PubMed ID: 32756468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. State of the art in CAR T cell therapy for CD19+ B cell malignancies.
    Frigault MJ; Maus MV
    J Clin Invest; 2020 Apr; 130(4):1586-1594. PubMed ID: 32235098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hairy cell leukemia: present and future directions.
    Kreitman RJ
    Leuk Lymphoma; 2019 Dec; 60(12):2869-2879. PubMed ID: 31068044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hairy cell leukemia - immunotargets and therapies.
    Basheer F; Bloxham DM; Scott MA; Follows GA
    Immunotargets Ther; 2014; 3():107-20. PubMed ID: 27471703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective effects of adenosine deaminase in the striatum.
    Tamura R; Ohta H; Satoh Y; Nonoyama S; Nishida Y; Nibuya M
    J Cereb Blood Flow Metab; 2016 Apr; 36(4):709-20. PubMed ID: 26746865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central nervous system involvement by Waldenström macroglobulinaemia (Bing-Neel syndrome): a multi-institutional retrospective study.
    Castillo JJ; D'Sa S; Lunn MP; Minnema MC; Tedeschi A; Lansigan F; Palomba ML; Varettoni M; Garcia-Sanz R; Nayak L; Lee EQ; Rinne ML; Norden AD; Ghobrial IM; Treon SP
    Br J Haematol; 2016 Mar; 172(5):709-15. PubMed ID: 26686858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe fludarabine neurotoxicity after reduced intensity conditioning regimen to allogeneic hematopoietic stem cell transplantation: a case report.
    Annaloro C; Costa A; Fracchiolla NS; Mometto G; Artuso S; Saporiti G; Tagliaferri E; Grifoni F; Onida F; Cortelezzi A
    Clin Case Rep; 2015 Jul; 3(7):650-5. PubMed ID: 26273463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The double-edged sword: Neurotoxicity of chemotherapy.
    Magge RS; DeAngelis LM
    Blood Rev; 2015 Mar; 29(2):93-100. PubMed ID: 25445718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suberoylanilide hydroxamic acid (SAHA) and cladribine synergistically induce apoptosis in NK-LGL leukaemia.
    Sun X; Hasanali ZS; Chen A; Zhang D; Liu X; Wang HG; Feith DJ; Loughran TP; Xu K
    Br J Haematol; 2015 Feb; 168(3):371-83. PubMed ID: 25284154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relapsed and refractory pediatric acute myeloid leukemia: current and emerging treatments.
    Davila J; Slotkin E; Renaud T
    Paediatr Drugs; 2014 Apr; 16(2):151-68. PubMed ID: 24158739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hairy cell leukemia-new genes, new targets.
    Kreitman RJ
    Curr Hematol Malig Rep; 2013 Sep; 8(3):184-95. PubMed ID: 23892906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy-induced polyneuropathy. Part I. Pathophysiology.
    Brzeziński K
    Contemp Oncol (Pozn); 2012; 16(1):72-8. PubMed ID: 23788859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bendamustine associated with irreversible ascending paralysis.
    Alhafez A; Aljitawi OS; Lin TL; Ganguly S; Abhyankar S; McGuirk JP
    Case Rep Hematol; 2013; 2013():931519. PubMed ID: 23533850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoconjugates and new molecular targets in hairy cell leukemia.
    Kreitman RJ
    Hematology Am Soc Hematol Educ Program; 2012; 2012():660-6. PubMed ID: 23233649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.